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Abstract Objective The aim of this study was to
compare the diagnostic accuracy of myocardial perfu-
sion imaging (MPI) by positron emission tomography
(PET) with the diagnostic accuracy of MPI by single
photon emission computed tomography (SPECT) in
two comparable patient cohorts, using coronary angi-
ography (CA) as the standard of reference. Methods A
‘‘SPECT-group’’ of 80 patients (15 female, 65 male;
mean age 60 ± 9 years) and a ‘‘PET-group’’ of 70
patients (14 female, 56 male; mean age 57 ± 10 years)
underwent a one day stress/rest examination either
with attenuation-corrected 13N-ammonia PET or atten-
uation-corrected 201TlCl SPECT or 99mTc-hexakis-
methoxy-isobutyl-isonitril (MIBI) SPECT. PET and
SPECT results were semiquantitatively graded using a
6-segment heart model. All patients underwent CA,
and stenoses were graded as a diameter reduction
C50%. Results Coronary findings between both groups
did not significantly differ at CA. For the SPECT-
group overall sensitivity and specificity for localisation
of stenoses was 77% and 84%. Respective values for
the PET-group were 97% and 84%. The specificity of
MPI by SPECT in the detection of ischemia was 74%
and 91% for MPI by PET. The diagnostic accuracy of
MPI improves when the individual coronary domi-
nance and previous coronary revascularisations are
taken into account. Conclusion MPI by 13N-ammonia
PET is more sensitive in the detection and localisation
of coronary stenoses, and more specific in the detection
of ischemia than MPI by 201TlCl/99mMIBI SPECT.
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CA Coronary angiography
CAD Coronary artery disease
MPI Myocardial perfusion imaging
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Introduction
Almost 2 decades ago, first reports on the diagnostic
accuracy of myocardial perfusion imaging (MPI) by
positron emission tomography (PET) have described
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its superiority over single photon emission computed
tomography (SPECT) in the diagnosis of coronary
artery disease (CAD) [1]. Compared to SPECT, PET
offers several potential advantages, such as: a higher
spatial resolution, lower effective dose due to greater
counting efficiency, and higher temporal resolution,
allowing fast dynamic imaging of tracer kinetics and
thus absolute quantification of myocardial perfusion
[2–4]. These advantage have presumably influenced
the results of consecutive studies, confirming the
higher sensitivity and specificity of PET [1, 5–8].
However, such studies have remained sparse and
comparability is hampered by a large variability of
protocols used. Therefore, more data are required to
define the added value of PET over SPECT justifying
the use of a more complex and expensive technique.
This would also help to increase the use of PET MPI,
which has remained very limited in daily clinical
routine, although the availability of PET cameras has
dramatically increased, mainly because of its clinical
role in oncology [9].
Therefore, the aim of this study was to compare
the diagnostic accuracy of MPI by PET with the
diagnostic accuracy of MPI by SPECT in two
comparable patient cohorts, using coronary angiog-
raphy (CA) as the standard of reference.
Methods
Patients
A ‘‘SPECT-group’’ of 80 patients (15 female, 65 male;
mean age 60 ± 9 years; age range 36–76 years)
underwent MPI by SPECT for further evaluation of
known CAD (n = 55) or because of suspected CAD
(n = 25). Similarly, a ‘‘PET-group’’ of 70 patients (14
female, 56 male; mean age 57 ± 10 years; age range
36–73 years) underwent MPI by PET for further
evaluation of known CAD (n = 49) or because of
suspected CAD (n = 21). The use of SPECT or PET
for MPI was determined by the referring physician. All
patients (n = 150) underwent coronary angiography.
MPI SPECT acquisition
Patients were instructed to fast and discontinue
antiischemic cardiac medication 24 h before the
examination. All patients underwent a 1 day stress/
rest protocol. Rest data was acquired after approxi-
mately 75–85 MBq 201Thallium-Chlorid (TlCl) were
injected into a right antecubital vein. For stress data
patients underwent a treadmill exercise protocol:
during the last 60–90 s of peak exercise (age-
predicted maximal heart rate, estimated by 220—
age) the patient received 600–800 MBq 99mTc-hexa-
kis-methoxy-isobutyl-isonitril (MIBI) intravenously;
heart rate and blood pressure were measured every
2 min, and ECG was monitored continuously.
If patients were unable to undergo treadmill
exercise, an intravenous infusion of dipyridamole
(140 lg/kg/min) over 4 min [10] and a bolus of 600–
800 MBq 99mTc-MIBI were injected 8 min after the
beginning of the dipyridamole infusion.
SPECT data at rest were acquired directly after
injection of the tracer while SPECT data for stress
were acquired with one hour delay, both with a triple-
detector camera (PRISM 3000, Picker, Bedford
Heights, OH, USA) with the following parameters:
a low-energy, high-resolution collimator; a 20%
symmetric window at 140 keV; a 64 9 64 matrix;
an elliptic orbit with step-and-shoot acquisition at 3
intervals over 180; and a 20-s dwell time per stop.
For attenuation correction simultaneous transmis-
sion measurements with either a 99mTc line source for
examinations with 201ThCl, or a 153Gadolinium line
source for examinations with 99mTc-MIBI were
acquired.
MPI PET acquisition
Patients were instructed to fast and discontinue
antiischemic cardiac medication 24 h before the
PET examination. Studies were performed with a
GE Advance PET scanner (GE Medical Systems,
Milwaukee, Wisconsin; axial field of view
35 9 4.25 mm). Rest data was acquired directly after
an injection of 700–900 MBq of 13N-ammonia into
a peripheral vein by the bolus technique. Stress
data was acquired approximately 5 halftimes
(1 hour) after the acquisition of the rest data, starting
with a 4-min dipyridamole infusion (140 lg/kg/min),
which was followed by a second bolus of 700–
900 MBq of 13N-ammonia, 8 min after the beginning
of the dipyridamole infusion. Stress data acquisi-
tion was started directly after the second bolus of
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13N-ammonia. Serial transaxial tomographic images
of the heart (12 9 10-s, 4 9 30-s, 1 9 60-s and
2 9 300-s frames) were acquired for all rest and
stress data. After 15-min acquisition, a 20-min
transmission scan for photon attenuation correction
was performed using an external 68Germanium
source as previously reported [11].
Analysis of MPI data
PET and SPECT images were transferred to external
workstations. On reformatted short-axis, vertical
long-axis, and horizontal long-axis slices, encompass-
ing the entire left ventricle, the left ventricle was
subdivided into six segments (anterior, apical, infe-
rior, posterior, lateral, septal), as previously published
[12]. Two independent observers, blinded to the
results of coronary angiography, semiquantitatively
graded tracer uptake for each segment in two planes in
consensus: normal uptake (grade 0), mildly abnormal
(grade 1), moderately abnormal (grade 2) or severely
abnormal (grade 3) of uptake. After calculating the
mean grade of both planes, a grade C1.5 in at least one
segment was defined as pathologic.
Coronary angiography
CA was performed according to standard techniques
and multiple views were stored on a CD-ROM. The
angiograms were evaluated by an experienced
observer who was blinded to the results from SPECT
and PET. The coronary arteries were segmented
according to the guidelines of the American Heart
Association [13] and analysis was performed in all
vessels with a luminal diameter of at least 1.5 mm,
excluding those vessels distal to complete occlusions.
Each vessel segment was scored as being stenosed,
defined as a diameter reduction of C50%, which was
considered the standard of reference for the assess-
ment of coronary artery disease, as it is generally
assumed that lesions above this cut off may induce
detectable perfusion defects.
Left ventricular segments (as defined above) were
assigned to vascular territories as previously pub-
lished, with and without taking into account the
individual coronary dominance [14, 15] (Table 1).
Furthermore, previous coronary interventions were
taken into account for the determination of the
diagnostic accuracy of SPECT and PET.
Statistical analysis
Quantitative variables were expressed as
mean ± standard deviation and categorical variables
as frequencies, median (25th, 75th percentiles), or
percentages.
All statistical analysis was performed using SPSS
software (SPSS 12.0.1, Chicago, IL, USA). The
clustered nature of the data [i.e., the fact that there
were not 480 independent segments with SPECT (or
420 with PET) but instead clusters of segments in 80
(70 with PET) patients] was taken into account.
Sensitivity and specificity were calculated from
chi-squared-tests of contingency. Because of the
interdependencies between different segments, the
statistics were calculated on a per-segment and on a
per-patient basis (presence of at least one positive
finding or absence of positive findings in each
patient). CA was considered the standard of reference.
To determine differences between the two groups
(SPECT and PET), Student’s t-tests for independent
samples were performed for the variables: age and
BMI; chi-squared-tests were performed for all other
variables. A P-value of \0.05 was considered to
indicate statistical significance.
Table 1 Vascular
territories and coronary
dominance
LAD: left anterior
descending artery; CX:
circumflex artery; RCA:
right coronary artery
Right dominant Left dominant Balanced
Segment 1 (anterior) LAD LAD LAD
Segment 2 (apical) RCA, LAD LAD LAD, CX, RCA
Segment 3 (inferior) RCA LAD, CX, RCA RCA
Segment 4 (posterior) RCA LAD, CX, RCA RCA, CX
Segment 5 (lateral) RCA, CX CX CX
Segment 6 (septal) RCA LAD LAD, RCA
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Results
CA and MPI (SPECT or PET) were successfully
performed in all patients (n = 150) (Figs. 1 and 2).
CA revealed 122 patients (81%) to have CAD
(defined as at least one coronary lesion with luminal
narrowing C50%). Patients undergoing SPECT or
PET did not differ among each other with regard to
age, gender, BMI, cardiovascular risk, history of
myocardial infarction, and particularly not with
regard to coronary findings (Tables 2 and 3).
Seventeen patients (21%) in the SPECT-group had
previous coronary revascularisation [10 9 coronary
artery bypass graft surgery (CABG), 7 9 percuta-
nous coronary intervention (PCI)], and 13 patients
(19%) in the SPECT-group had previous coronary
revascularisation (7 9 CABG, 4 9 PCI).
The diagnostic accuracy of MPI was calculated for
both groups with and without taking into account
successful revascularization and considering coro-
nary dominance (Table 3).
MPI SPECT analysis
The overall sensitivity of SPECT to determine CAD in
a patient was 85%. Sensitivity was unchanged when
coronary arteries with previous successful revascular-
isation (PCI or bypass) were rated as ‘‘not stenosed’’.
Specificities were not calculated, due to the small
number of patients without coronary stenoses [16].
With respect to the localisation of the SPECT
findings (in 480 segments) and the localisation of CA
findings in the three coronary arteries, overall sensi-
tivity and specificity was 77% and 84% (values for
each coronary artery are demonstrated in Fig. 3). In
general, sensitivities and specificities increased when
previous revascularisation procedures and/or coro-
nary dominances were taken into account (Table 4,
Fig. 3).
Thirty patients (38%) had reversible perfusion
defects (ischemia); specificity was 74%; sensitivity
was not calculated because MPI is the accepted
reference standard for the detection of ischemia.
MPI PET analysis
Overall sensitivity for the determination of CAD with
PET was 96%. Sensitivity improved when coronary
Fig. 1 Stress and rest SPECT images reveal an irreversible
inferior basal perfusion defect (open arrow heads), representing
a myocardial scar. At stress an additional minor lateral
perfusion defect (solid arrow heads) is indicative of minor
ischemia. VLA: vertical long axis; HLA: horizontal long axis;
SA: short axis
Fig. 2 Stress and rest PET
images reveal an
irreversible apical perfusion
defect (open arrow heads),
representing a myocardial
scar. At stress an additional
inferior perfusion defect
(solid arrow heads) is
indicative of minor
ischemia. VLA: vertical
long axis; HLA: horizontal
long axis; SA: short axis
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arteries with previous revascularisation (PCI or
bypass) were rated as ‘‘not stenosed’’ (Table 4).
Overall sensitivity and specificity for the localisa-
tion of the PET findings (in 420 segments) with
respect to the localisation of CA findings, was 97%
and 84% (values for each coronary artery are
demonstrated in Fig. 3). Similar to SPECT, sensitiv-
ities and specificities increased when previous
revascularisation procedures and/or coronary domi-
nances were taken into account (Table 4, Fig. 3).
Ischemia was detected by PET in 16 patients
(23%); specificity was 91% and 95%; sensitivity was
not calculated.
Discussion
Despite the suggested superiority of MPI by PET
over MPI by SPECT, SPECT is primarily used in
clinical routine today. Our study adds to the previous
knowledge on MPI using SPECT and PET: (a) in a
direct comparison of 2 patient population with
comparable prevalence and extent of CAD, MPI by
13N-ammonia PET is more sensitive and more
specific in the detection and localisation of coronary
stenoses than MPI by 201TlCl/99mMIBI SPECT; (b)
the specificity in the overall detection of ischemia is
higher with MPI by 13N-ammonia PET; (c) individual
coronary dominance and previous coronary
Table 2 Patient demographics
All patients SPECT-group PET-group Significance (P)
Number of patients 150 80 70
Female/male 29/121 15/65 14/56 V2: 0.85
Age (years) 59 ± 10 (36–76) 60 ± 9 (36–76) 57 ± 10 (36–73) t-test: 0.71
BMI (kg/m2) 25.7 ± 3.2 (19.5–37.5) 25.6 ± 2.9 (19.5–33.3) 25.8 ± 3.7 (20.3–37.5) t-test: 0.67
Previous myocardial infarction 84 (56%) 40 (50%) 44 (63%) V2: 0.11
Cardiovascular risk factors
Nicotine abuse 62 (41%) 31 (39%) 31 (44%) V2: 0.49
Diabetes mellitus 17 (11%) 4 (5%) 13 (19%) V2: \0.01
Dyslipidemia 61 (41%) 32 (40%) 29 (41%) V2: 0.86
Hypertension 42 (28%) 21 (26%) 21 (30%) V2: 0.61
Positive family history 34 (23%) 14 (18%) 20 (29%) V2: 0.11
Obesity 31 (21%) 20 (25%) 11 (16%) V2: 0.16
CCS classification
I 46 (31%) 25 (31%) 21 (30%) V2: 0.87
II 46 (31%) 26 (33%) 20 (29%) V2: 0.60
III 38 (25%) 16 (20%) 22 (31%) V2: 0.11
IV 20 (13%) 13 (16%) 7 (10%) V2: 0.26
Quantitative variables are expressed as mean ± standard deviation (range); categorical variables are expressed as frequencies
(percentages); CCS: Canadian Cardiovascular Society; BMI: body mass index
Table 3 Coronary angiography findings
SPECT-group
(n = 80)
PET-group
(n = 70)
P
Stenosis in any
coronary segment
69 (86%) 53 (76%) 0.09
In LAD segments 58 (73%) 48 (69%) 0.59
In CX segments 52 (65%) 35 (50%) 0.06
In RCA segments 48 (60%) 40 (57%) 0.72
Coronary artery disease
One vessel 13 (17%) 13 (19%) 0.71
Two vessel 23 (29%) 10 (14%) \0.05
Three vessel 33 (41%) 30 (43%) 0.84
Coronary dominance
Right 29 (36%) 35 (50%) 0.11
Left 14 (18%) 6 (9%) 0.11
Balanced 12 (15%) 7 (10%) 0.36
Not assessable 25 (31%) 22 (31%) 0.98
Variables are expressed as frequencies (percentages); LAD:
left anterior descending artery; CX: circumflex artery; RCA:
right coronary artery
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revascularisations need to be taken into account when
determining the diagnostic accuracy of MPI.
Data of direct comparison of MPI using SPECT and
PET is sparse and inhomogeneous [1, 5–8]. Tamaki
and colleagues [1] have compared 13N-ammonia PET
with 201TlCl SPECT, not using attenuation correction,
and more importantly, in groups of patients with a
prevalence of CAD of over 90%, leading to very high
and not significantly different sensitivities for SPECT
and PET.
Comparing 82Rubidium PET with 201TlCl SPECT
Stewart and colleagues [5] have demonstrated a
Fig. 3 Regional sensitivity
and specificity for the
localisation of SPECT and
PET findings in the territory
subtended by the left
anterior descending artery
(LAD) (a), the circumflex
artery (CX) (b), and the
right coronary artery (RCA)
(c). Results are
demonstrated overall,
considering previous
revascularisation,
considering coronary
dominance, and considering
coronary revasc.
(revascularisation) and
coronary dominance
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higher specificity of PET in localising coronary
stenoses, but this observation might have been influ-
enced by a referral bias, associated with their study
design, where patients with more advanced disease
were preferentially referred to PET scanning [17]. On
the other hand, their results were confirmed by Go and
colleagues [6], using the same tracers, but with a
different study design, less prone to referral bias.
Furthermore, Marwick and colleagues [7] con-
cluded in their study, that PET can identify smaller
and less ischemic areas subtended by milder coronary
stenoses, but in their comparison of 82Rubidium PET
and 201TlCl SPECT, attenuation correction was only
used for PET. Recently, Bateman and colleagues [8]
described a higher diagnostic accuracy of 82Rubidium
PET compared to 99mTc sestamibi SPECT, but again
attenuation correction was only used for PET,
although it has been shown to substantially improve
accuracy in SPECT [18–20].
As far as comparisons of studies with different
study designs are reasonable, the results of our study
are largely in line with previous work [1, 5–8],
placing PET above SPECT with regard to diagnostic
accuracy of coronary stenosis detection and localisa-
tion. However, the fact that we have used attenuation
correction for SPECT, may explain why the differ-
ence between PET and SPECT was slightly smaller in
our study compared to the previous reports.
In addition, we could demonstrate for the first
time, that PET is more specific in the detection of
ischemia than SPECT. As MPI is the reference
standard for the detection of ischemia, the
determination of the sensitivity of PET and SPECT
is not possible. Nonetheless, hypothesising that
normal myocardial perfusion must be associated with
coronary arteries being free of stenoses, we calcu-
lated specificities of both methods, and could
demonstrate the superiority of MPI by PET.
Finally, when using CA as the standard of
reference, the knowledge of the individual coronary
dominance is crucial for an adequate (but blinded)
assignment of significant coronary artery stenoses to
myocardial segments with reduced perfusion in MPI
with SPECT and PET. Similarly, previous coronary
revascularisations may interfere with the results of a
study when a myocardial scar in MPI is attributed to
an unstenosed vessel in CA (after reperfusion), which
would lead to an incorrect false positive rating. Our
study confirms a relevant impact of coronary dom-
inance and of previous coronary revascularisations on
the accuracy of segmental MPI, which should be kept
in mind when planning upcoming studies on diag-
nostic accuracy.
Limitations of the study
The clinical assignment of patients to either the
SPECT-or the PET-group might have been biased by
their referring physicians. However, we could dem-
onstrate no significant differences in age, gender,
BMI, CCS classification, or prevalence or extent of
CAD between both groups, indicating an excellent
match of the two groups.
Table 4 Diagnostic
accuracy of MPI with
SPECT and PET
MPI: myocardial perfusion
imaging; CAD: coronary
artery disease; na: not
assessed
SPECT-group PET-group
Sensitivity
(%)
Specificity
(%)
Sensitivity
(%)
Specificity
(%)
Detection of CAD
Overall 85 na 96 na
Regarding previous revascularisation 85 na 98 na
Localisation of stenoses
Overall 77 84 97 84
Regarding previous revascularisation 78 82 97 82
Regarding coronary dominance 85 88 99 92
Regarding revascularisation &
dominance
86 88 99 93
Detection of ischemia na 74 na 91
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Conclusion
13N-ammonia PET is more sensitive and specific in
the detection and localisation of coronary stenoses,
and more specific in the detection of ischemia than
201TlCl/99mMIBI SPECT, even when attenuation
correction is used for MPI and SPECT. The diagnos-
tic accuracy of MPI can be improved when the
individual coronary dominance and previous coro-
nary revascularisations are taken into account.
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